VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Insights

The Best Small CRO for Biostatistics and FDA Submissions

36+ Years. Hundreds of successful clients and projects.

Insights

The Best Small CRO for Biostatistics and FDA Submissions

36+ Years. Hundreds of successful clients and projects.

Insights

The Best Small CRO for Biostatistics and FDA Submissions

36+ Years. Hundreds of successful clients and projects.

2 min read time

Why BSC® Outperforms Larger CROs

Location: Philadelphia, United States + Remote

Focus: Biostatistics • Regulatory Strategy Consulting • Clinical Data Analysis CRO

Track Record: 36+ years in business, Hundreds of approved clients and projects.

We specialize in the statistics and regulatory strategy that make or break an FDA submission.

Our work spans breakthrough medical devices, life-saving therapeutics, and diagnostics that have changed patient care.

  • Proven Success: Since 1986, we’ve guided 750+ projects through the FDA process.

  • Trusted by Industry Leaders: From early-stage medtechs to global giants whose internal folks need additional support.

  • High-Complexity Expertise: Adaptive designs, Propensity Score Matching, Bayesian methods, Endpoint creation, and real-world evidence that stands up to FDA scrutiny.

Specialized Expertise for Complex FDA Challenges

All of our statisticians and programmers do the work themselves — you’ll never be sold by one person during the business development call, and transferred to another after a contract is signed.

Our Services Include:

  • Clinical trial design that withstands FDA scrutiny

  • Statistical analysis plans aligned with your regulatory strategy

  • Data management and programming that pass audits

  • Complete biostatistics CRO regulatory submission packages (510(k), PMA, NDA)

Key Advantage: We know what FDA reviewers need to see — and how to present it.

When to Choose a Small CRO

Large CROs

Best for: Large-scale, global trials with high-volume patient recruitment.

Small CROs like BSC®

Best for: Complex biostatistical problems, adaptive trial designs, and strategic regulatory submissions.

If your submission requires specialized statistical expertise and tight regulatory alignment, a small CRO will often outperform a large generalist.

How to Evaluate a Biostatistics CRO

When choosing a partner for your FDA submission, look for:

  • Regulatory Track Record: Demonstrated approvals in your therapeutic area

  • Statistical Depth: Direct experience with your analytical challenges

  • Quality Systems: SOPs and compliance that withstand inspection

  • Technology Infrastructure: Current data management and analytics platforms

  • Senior Team Access: Direct communication with decision-makers

  • Proven References: Verified success with similar FDA projects

Why BSC® Is the Right Choice

We combine deep regulatory knowledge, advanced statistical methods, and direct senior-level engagement to get your submission approved.

Every month of delay in FDA clearance can cost millions in lost market opportunity.

Don’t risk it with a generalist CRO.

Let’s Get Your FDA Submission Approved

If your project demands sophisticated statistical analysis and proven regulatory strategy consulting, we should talk.

Email: hello@biomedstat.com

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.